Shows
The Promise of Personalized MedicineRethinking Precision Medicine: From Mutations to Molecular PathwaysIn this episode of The Promise of Personalized Medicine, Perry sits down with Aditya Pai, a genetic counselor by training and a leader at Genialis, where he works at the intersection of biology-driven analytics, AI, and oncology drug development.Aditya brings a practitioner’s and innovator’s perspective to what personalized medicine truly means today—moving beyond one-size-fits-all care and even beyond single-gene mutations, toward a more holistic understanding of disease biology. Together, they explore how RNA-based insights, pathway-level analysis, and machine learning are reshaping how cancers are understood, treated, and studied across the drug development lifecycle.A...
2026-01-1323 min
Talking Precision MedicineIan Simon | When following the science isn’t enough: risk, communication, and the future of biotechnology | TPM podcast #52In this episode, I’m joined by my longtime friend Ian Simon, Head of Biotechnology at Aspis Intelligence. Ian’s path runs from grad school vaccine research at Yale to senior roles at the White House, HHS, NIH, the State Department, and the Office of Long Covid. We talk about de-risking young biotech companies, what Covid taught us about science and public health, and how new technologies like AI might change how we do science altogether. TPM E52 highlights >Episode 52 links:Ian Simon on LinkedInAspis Intelligence
2025-12-1239 minTalking Precision MedicineMichelle Chen | Using AI to derisk gene therapy and genetic medicine | TPM podcast #51In this episode Rafael sits down with Michelle Chen, President and CEO of Form Bio, a techbio company using AI to advance genome engineering and the development of genetic medicines. Michelle shares her zigzag journey from scientist to executive, how her team is tackling the biggest bottlenecks in gene therapy, and why AI has become essential in designing safer, more effective treatments. TPM E51 highlights >Episode 51 links:Michelle Chen on LinkedInForm Bio
2025-11-1336 minTalking Precision MedicineMike Rossi, ConcertAI | Real world data and artificial intelligence turn anecdote to evidence | TPM podcast #50Today I’m joined by Mike Rossi, Vice President of Translational Science and Multi-modal Real-World Evidence Solutions at ConcertAI. Mike has built a career at the intersection of genomics, data science, and oncology, helping to bridge the gap between research and real-world clinical practice. We talk about what real-world data really means, how it becomes actionable evidence, and what it takes to turn the messy reality of patient care into insight that changes lives.TPM E50 highlights >Episode 50 links:Mike Rossi on LinkedInConcertAI
2025-10-3044 min
The Brainiac BlueprintAI-Powered Precision Oncology | Aditya Pai of Genialis | The Brainiac Blueprint PodcastIn this episode of The Brainiac Blueprint Podcast, we’re joined by Aditya Pai, Head of Business Development at Genialis, to explore how AI is transforming precision oncology and shaping the future of cancer care.Aditya shares how Genialis uses machine learning to develop next-generation biomarkers, support pharma and biotech companies, and ultimately help bring life-saving medicines to patients. He also opens up about his personal connection to cancer and the book he co-authored, A Race Called Life, inspired by his mother’s journey.
2025-09-1758 min
Life Sciences TodayTherapeutic Response with GenialisWe’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Miha Štajdohar, Co-Founder and CTO at Genialis. Genialis develops and markets an AI supermodel that can predict Therapeutic Response for cancer patients.
Check out the main topics of discussion for this episode of the Life Sciences Today podcast:
Tell me about your journey to Genialis?
Who are your customers?
How do you create value for your customers?
How do you capture value from them?
What are 3 things you want to achieve for your cus...
2025-08-2933 minTalking Precision MedicineMida Pezeshkian, Stema_cg | Launching products in healthcare: The most important framework is flexibility | TPM podcast #49Joining us on this episode is Mida Pezeshkian, an old colleague and friend. Mida’s career has spanned from the depths of stem cell science as a student to her current focus on product management in healthcare. We talk about what it really takes to launch products in this space, and how she helps customers bring truly transformational innovations to market.TPM E49 highlights >Episode 49 links:Mida Pezeshkian on LinkedInSTEMA_cgThe Lab
2025-08-2944 minTalking Precision MedicineMichael Montalto, Amgen | How to have the biggest impact on patients: a career of invention, innovation, and implementation | TPM podcast #48Today on the show, I’m joined by Michael Montalto, vice president of precision medicine at Amgen. Amgen is widely recognized as one of the most successful pharmaceutical companies in translating research and development into approved therapies. A key part of that success comes from their focus on precision medicine, and Mike brings a unique perspective from the forefront of that work.TPM E48 highlights >Episode 48 links:AmgenMichael Montalto on LinkedInGenialis presents a poster at ISMB/ECCB 2025
2025-07-2443 minTalking Precision MedicineTom Neyarapally, Archetype Therapeutics | A new paradigm for generative AI drug discovery: more accurate shots on a much wider goal | TPM podcast #47Joining us on this episode is Tom Neyarapally, co-founder and CEO of Archetype Therapeutics, an exciting new AI-driven company in the drug discovery space. Archetype is an AI-native biotech pioneering the use of generative chemogenomics and patient clinicogenomic data to virtually screen billions of potential drug candidates each day.TPM E47 highlights >Episode 47 links:Archetype TherapeuticsTom Neyarapally on LinkedIn “Exploring a “Patient-First” Path in Drug Discovery”, a LinkedIn article by Tom Neyarapally, Paul McDonagh, and Rafael Rosengarten
2025-06-2442 minTalking Precision MedicineStéphane Budel, DeciBio | Precision medicine is our future and our fate | TPM podcast #46Stéphane Budel, founding partner at DeciBio, joins the Talking Precision Medicine Podcast to explore the future of the field. He unpacks how liquid biopsy, multi-omics, and AI are opening new doors for personalized care, why the diagnostics business model is holding innovation back, and what it will take to make complex tech usable for clinicians and patients alike.TPM E46 highlights >Episode 46 links:DeciBioStephane Budel on LinkedInDeciBio’s White Paper on AI in Drug Development (with contributions from Rafael Rosengarten)
2025-05-1950 min
Beginner's MindEP 158 - Rafael Rosengarten: Why 90% of Cancer Drugs Fail — and the Radical AI Fix You’ve Never Heard Of Most cancer drugs fail. Not because the science is wrong—because we’re solving the wrong problems.The cost? Over $2 billion per failure. And for the patient waiting on a miracle—there’s no second chance.Behind the headlines of “precision medicine,” there’s a deeper story nobody’s telling. Until now. 🎯 Enter Rafael Rosengarten, the scientist-turned-founder who’s rewriting the rules of drug development.In this gripping conversation, we unpack how RNA, AI, and deep empathy could finally close the loop between biology, data, and the patient in the...
2025-05-162h 02Talking Precision MedicineAnna Berkenblit & Sudheer Doss, PanCAN | On a mission to beat an ignoble killer: pancreatic cancer | TPM podcast #45Today’s guests are Anna Berkenblit, Chief Scientific and Medical Officer at the Pancreatic Cancer Action Network, and Sudheer Doss, Chief Business Officer at PanCAN. The Pancreatic Cancer Action Network is the leading organization dedicated to advancing progress against pancreatic cancer. It empowers patients and caregivers, drives early detection strategies, and revolutionizes the development of advanced and personalized treatments.TPM E45 highlights >Episode 45 links:Anna Berkenblit on LinkedInSudheer Doss on LinkedInPanCANFor access to data through PanCAN’s SPARK platform, please visit: PanCAN.org/sparkFor more information, contact PanCAN Patient Services with questions about any type of pancreatic c...
2025-04-2246 minTalking Precision MedicineNajat Khan | Radical Transformation: Becoming a Medicines Company with End-to-End AI | TPM #44Today’s guest is Najat Khan, Chief R&D Officer and Chief Commercial Officer at Recursion Pharmaceuticals.Recursion is widely recognized as one of the most visible—and so far, most successful—companies to emerge from the tech-bio movement. Many consider it the current industry leader.It has become an iconic name in the field of artificial intelligence for drug discovery.TPM E44 highlights >Episode 44 links:Najat Khan on LinkedInRecursion
2025-03-2838 minTalking Precision MedicineRyan Fukushima | Reinventing diagnostics: The superpower of not knowing what can’t be done | TPM #43What a pleasure to welcome today’s guest, Ryan Fukushima, chief operating officer of TempusAI. Not only has Ryan helped build Tempus brick by brick from the earliest days, he is also CEO of Pathos AI, a biotech company using real world data and AI to develop true precision medicines. I don’t know how he juggles it all, but unless you’ve been hiding out these last few years, Tempus has become a household name in our industry, completing a highly successful IPO last year. But no need to take my word for it, come on in and have a...
2025-02-2643 min
Faces of Digital HealthDecoding Cancer: AI, Biomarkers & Precision MedicineWhen it comes to cancer, prevalence is increasing and there is still a lot we don't understand about the factors and causes of cancers.Many studies have clearly demonstrated the benefits of biomarker testing for cancer therapy. However, broadly speaking, roughly 30% of cancer patients are eligible for targeted therapies based on their tumor profile. And even when the biomarket is present, roughly 30% of the eligible patients respond to these treatments.We have a lot more to uncover.In the discussion you are about to hear, I spoke with Luka Ausec...
2025-02-2441 minTalking Precision MedicineThe journey to the top of life sciences technology: a lifetime of listening and learning | Talking Precision Medicine #42Today my guest is Joydeep Goswami, newly appointed President and CEO of the storied biotechnology company LGC. Joydeep is also a strategy advisor to Genialis. Join us as we discuss his remarkable career and lessons learned at each step of the way.
Come on in and have a listen.
Episode 42 links:
TPM E42 for highlights and links from this episode >
Tempus Announces a Collaboration With Genialis
Genialis’ Upcoming Events
2025-01-3147 min
Curiosity with KristenRafael Rosengarten - CEO of GenialisIn this episode, we’re joined by Dr. Rafael Rosengarten, CEO and co-founder of Genialis, the RNA biomarker company transforming how healthcare delivers outcomes for patients, families, and communities. A visionary leader who puts people first, Rafael’s career spans nearly two decades of groundbreaking biomedical research in genetics, immunology, and bioengineering.Under his leadership, Genialis develops clinically actionable biomarkers informed by the most diverse cancer data sets, empowering targeted therapies and immuno-therapies to guide treatment decisions. Rafael is also a co-founder and board member of the Alliance for AI in Healthcare, advocating glob...
2025-01-3137 minTalking Precision MedicineThe view from 30,000: Healthcare & life science AI in the cloud | Talking Precision Medicine #41This episode features a conversation with Shweta Maniar, who leads the Healthcare and Life Science effort at Google cloud. In just a few short years, artificial intelligence has gone from the stuff of hype and fairy tale to powerful and ubiquitous tools for all aspects of R&D and healthcare delivery. Google has been central to this sea change. I discuss with Shweta how her organization helps make these advanced capabilities available to the masses, and so much more. Join us!
Episode 41 links:
TPM E41 for highlights and links from this episode >
Genialis™ Supermodel
Happy Holidays
Genialis' Upcoming Events
Gen
2024-12-1837 minTalking Precision MedicineWhat’s in a digital twin? Inventing new kinds of AI for biomedicine | Talking Precision Medicine #40Our guest this episode is Charles Fisher, co-founder and currently Chief Scientific Officer of Unlearn.AI. Unlearn has been a leader in the advancement of Digital Twins as a tool to drastically improve the efficiency of clinical trials. Not only a visionary scientist and trailblazing entrepreneur, Charles is fearless with his hot takes. So sit back and enjoy this free wheeling conversation!
Episode 40 links:
TPM E40 for highlights and links from this episode >
Potential of the Xerna™ TME Panel as a Predictive Biomarker (SITC 2024 Poster)
Genialis’ Upcoming Events
Genialis on LinkedIn
2024-11-1547 min
OgrodjeNejc Škoberne in gradnja z umetno inteligencoV zakulisju festivala DragonDays v Celju smo spregovorili z Nejcem Škobernetom.
Nejc se po zelo uspešni podjetniški in tehnološki zgodbi v Genialis in Meetings.bio odpravlja v novo pustolovščino z Sellestial.
V Sellestial poskušajo z uporabo napredne in sodobne umetne inteligence nadgraditi in modernizirati procese prodaje. Kako? S čim? Zakaj? Kako je razvoj produktov z/nad AI drugačen od "klasičnega" razvoja? Kaj razvijat "sam" in kaj "uporabit"? Itd, ipd...
Odličen vpogled v razvoj sodobnih produktov in razmišljanje o prihodnosti kjer je umetna inteligenca vedno bolj pomembn...
2024-10-151h 03Talking Precision MedicineLeave No Patient Behind—R&D Tools and Cutting Edge Diagnostics that Span the Globe | Talking Precision Medicine #39What a genuine pleasure to sit with Thierry Bernard, CEO of Qiagen. As I told Thierry, Qiagen is a truly iconic brand for anyone who came up through molecular biology laboratories in the past 30 years. Their products were ubiquitous, and crucial, to the success of our research. In this conversation, Thierry talks about his global vision for precision medicine, and his mantra that we leave no patient behind.
Episode 39 links:
TPM E39 for highlights and links from this episode >
Genialis™ krasID Poster at 6th Annual RAS-Targeted Drug Development Summit 2024
Genialis’ Upcoming Events
Genialis on LinkedIn
2024-10-0835 minTalking Precision MedicineZola-007: Giving T-cells the license to kill | Talking Precision Medicine #38What a pleasure to sit down with my long time colleague and friend, Art Krieg, to discuss his latest venture, Zola Therapeutics, and his adventures in the great outdoors. Art has launched and exited a number of innovative biotechs, each time delving deeper into mechanisms by which we can harness the immune system for therapeutic purposes. Join us as we discuss how — despite a well earned retirement — the siren song that led to Zola was strong enough to get Art back in the game.
Episode 38 links:
TPM E38 for highlights and links from this episode >
Genialis’ Upcoming Events
2024-08-2944 minTalking Precision MedicineCell therapy for T-cell malignancies—the science and business of developing curative medicines for patients in need | Talking Precision Medicine #37In this episode I chat with Dr Sarah Hein, co-founder and CEO of March Biosciences, a Houston Based biotech developing cell therapies for T-cell malignancies. Sarah is an old friend and colleague from our days as trainees at Baylor College of Medicine, where we both circulated among those with ambitions of entrepreneurship. Sarah has definitely made good in that regard, as a serial entrepreneur deeply enmeshed in Houston’s growing life sciences and healthtech ecosystem.
Episode 37 links:
TPM E37 for highlights and links from this episode >
Genialis’ Upcoming Events
Genialis™ krasID
2024-07-2239 min
The AI Healthcare PodcastRafael Rosengarten: CEO of GenialisIn this episode, I sit down with my friend, CEO of Genialis, and Co-founder, Board Director & Executive Committee Member of the Alliance for Artificial Intelligence in Healthcare, Rafael Rosengarten. To find more about Rafael, find him on Linkedin, genialis.com, or at theaaih.org. Episode is available on Apple Podcasts, Spotify, and Youtube. Dylan ReidYoutube:AIHealthcarePodcastX:@AIHealthcarePodLinkedin: The AI Healthcare Report
2024-06-1825 minTalking Precision MedicineTackling healthcare disparities and bridging the digital divide: it doesn’t have to be so hard | Talking Precision Medicine #36This episode features two guests, Jennifer Goldsack and Yashoda Sharma, of the Digital Medicine Society, or DiMe. We’re going to get into the nitty gritty of healthcare disparities in terms of access and outcomes, and how digital solutions are a big part of the overall solution.
Episode 36 links:
TPM E36 for highlights and links from this episode >
Genialis’ Upcoming Events
Genialis™ krasID
2024-05-2444 minTalking Precision MedicineThe Science and Art of De-risking Cancer Drug Development | Talking Precision Medicine #35In this episode Genialis CEO Rafael Rosengarten sat down with Dr. Carolina Haefliger, head of translational medicine at Debiopharm, the privately held Swiss biopharma company focused on oncology drug development. They talked about de-risking promising new cancer drugs, and what it takes from the science to the team to the technologies.
Episode 35 links:
Visit TPM E35 for highlights and links from this episode >
Learn more about Genialis™ krasID >
New Genialis RNA Biomarker Accurately Predicts KRAS Outcomes in Lung Cancer Patients >
2024-04-1231 minTalking Precision MedicineProfessional grade software — a key ingredient in cutting edge biomedical discovery | Talking Precision Medicine #34Today we turn the mic around, as our guest Adam Stasio hosts an excellent podcast of his own. Adam’s day job, however, is running SciMed, a boutique life sciences software development company. Adam and Genialis CEO Rafael Rosengarten discuss the state of scientific software, the importance of agility and communication, and approaches to building a lasting company culture.
Visit TPM E34 for highlights and links from this episode.
2023-12-1431 minTalking Precision MedicineNew Medicines from Evolutionary Pathways: Using Comparative Genomics to Treat Human Disease | Talking Precision Medicine #33Our guest today is Dr. Ashley Zehnder, co-founder and CEO of Fauna Bio. Fauna is a revolutionary young biotech company using comparative genomics of an array of non-traditional mammalian models to discover new therapeutic opportunities for people. What do ground squirrels have to do with treating battlefield trauma? Only one way to find out …
Visit TPM E33 for highlights and links from this episode.
2023-10-2742 min
Impact AITargeted Cancer Treatments with Rafael Rosengarten from GenialisNew research and technology are radically transforming cancer treatment, and, today, we find out how. I am joined by Genialis CEO and Co-Founder, Rafael Rosengarten to discuss his company’s mission to “outsmart cancer.” Genialis is revolutionizing cancer care by developing AI models that decode the biology behind different types of cancer and identify the most effective therapies for individual patients.In this episode, we discover how Genialis’ innovative approach of turning RNA sequencing data into tumor phenotype classification is remolding the landscape of precision medicine. Rafael explains the company’s methods of handling the high dimensionality and sparse...
2023-09-0424 minFaces of Digital HealthHow Can AI Help Predict Patient Drug Response? (Genialis)Drug development is undeniably expensive. For years, the pharmaceutical industry cited an estimate of 3 billion US dollars. However, a recent study published in 2020 discovered that the median cost actually falls between 985 million and 1.3 billion US dollars. Even within this range, it remains a substantial amount. The high cost primarily stems from the significant failure rate of new potential medications that never progress beyond clinical trials. Computational biology and AI have already assumed significant roles in drug development. The aspiration is for them to expedite the creation of new, more precise, and tailored medications. Today, we will delve into biotech...
2023-08-0837 minTalking Precision MedicineTo achieve personalized medicine, start by getting the dose right | Talking Precision Medicine #32In this episode, Genialis CEO Rafael Rosengarten sits down with Ajay Gopal, CEO and founder of Rx Studio. Rx Studio is a technology company using data science to tackle a major limitation to personalized medicine: drug dosing.
Visit TPM E32 for highlights and links from this episode.
2023-08-0239 minTalking Precision MedicineAI and Ethics in Healthtech: Who is Innovating Most? | Talking Precision Medicine #31In this episode, Genialis CEO Rafael Rosengarten speaks with BCG management consultant and healthcare innovation expert Amy MacDougall. They discuss emerging trends in healthcare, the role of AI, ethics and more, as well as BCG’s recently released 50 Most Innovative Companies List.
Visit TPM E31 for highlights and links from this episode.
2023-06-2934 minTalking Precision MedicinePeople first: building a company that inspires impactful work | Talking Precision Medicine #30This episode, Genialis’ thirtieth, is a bit different from the previous ones. CEO Rafael Rosengarten has not one, not two, but three guests, including the entire leadership team at Genialis. The gang discusses Genialis’ twin quests to build a great place to work and a business that makes a positive impact on the world.
Visit TPM E30 for highlights and links from this episode.
2023-05-3151 min
Midstage Startup Momentum#080 Genialis CEO & Co-Founder Rafael Rosengarten: Build a Great Company and a Great Business FollowsThe ongoing fight against cancer requires all hands on deck. Fortunately, tech startups are starting to harness the power of AI and machine learning to help in the fight against cancer. Genialis is one startup that uses AI in the precision medicine industry to ensure cancer patients are getting the right treatment.
Genialis CEO and co-founder Rafael Rosengarten recently sat down with startup coach Roland Siebelink to discuss the role his startup is playing in treating cancer patients more effectively. Rafael also spoke about the journey Genialis has been on and his personal journey as a first-time...
2023-05-2625 minTalking Precision MedicineCommunication, the key to building community | Talking Precision Medicine #29Our guest this episode is Dr. Susanna Harris, community lead at Vibe Bio. Susanna is a dedicated scientific communicator and an outspoken advocate for the mental health of PhD students and other science researchers. She has chronicled her journey from the academic lab bench to a venture incubator to a promising biotech company for a substantial social media following, and joins us today to dive into these topics and more.
Visit TPM E29 for highlights and links from this episode.
2023-01-2644 minTalking Precision MedicineA new way to finance drug development, for rare disease and beyond | Talking Precision Medicine #28In this episode, our host and Genialis CEO Rafael Rosengarten spotlights Vibe Bio. Vibe Bio is a new biotech aiming to disrupt how we finance drug development through stakeholder communities and cryptocurrency, starting in the rare disease arena. Our guest is Alok Tayi, co-founder and CEO of Vibe. Alok is a successful serial entrepreneur and a rare disease community member.
Visit TPM E28 for highlights and links from this episode.
2022-11-3045 min
Talking Precision MedicineWhat’s in a Name?: Endpoint Health’s Patient-Centric Northstar | Talking Precision Medicine #27This episode features Jason Springs, co-founder and CEO of Endpoint Health, an ascendant precision therapeutics company. Jason is a serial entrepreneur, who with the co-founders of his previous company, is building Endpoint Health to bring together under one roof the data science, diagnostics and therapeutics necessary to achieve truly personalized care.
Visit TPM E27 for highlights and links from this episode.
2022-06-2743 min
The Harry Glorikian ShowAt the Cutting Edge of Computational Precision Medicine, with Rafael RsengartenGenialis, led by CEO Rafael Rosengarten, is one of the companies working toward a future where there are no more one-size-fits-all drugs—where, instead, every patient gets matched with the best drug for them based on their disease subtype, as measured by gene-sequence and gene-expression data. Analyzing that data—what Rosengarten calls "computational precision medicine"—is already helping drug developers identify the patients who are most likely to respond to experimental medicines. Not long from now, the same technology could help doctors diagnose patients in the clinic, and/or feed back into drug discovery by providing more biological targets for bio...
2022-06-2143 minTalking Precision MedicineTaking charge of your health future with wearables and AI | Talking Precision Medicine #26In this episode 26, our host Rafael sits down with Harry Glorikian. Harry is an investor, author, podcaster and veteran of the healthtech industry. Harry walks us through his latest book, The Future You, and expounds on the ways that wearable devices, personal health data and artificial intelligence are changing healthcare as we know it.
Visit TPM E26 for highlights and links from this episode.
2022-02-2833 min
The Harry Glorikian ShowAt the Cutting Edge of Computational Precision Medicine, with Rafael RosengartenGenialis, led by CEO Rafael Rosengarten, is one of the companies working toward a future where there are no more one-size-fits-all drugs—where, instead, every patient gets matched with the best drug for them based on their disease subtype, as measured by gene-sequence and gene-expression data. Analyzing that data—what Rosengarten calls "computational precision medicine"—is already helping drug developers identify the patients who are most likely to respond to experimental medicines. Not long from now, the same technology could help doctors diagnose patients in the clinic, and/or feed back into drug discovery by providing more biological targets for bio...
2022-01-0443 minTalking Precision MedicineReal-Time Multiplexed Biomarkers: The Next Generation of Continuous Monitoring | Talking Precision Medicine #25Earlier this summer, Rafael sat down with Peter Vranes and Hitesh Mehta, co-founders of Nutromics. Nutromics is developing a next generation lab-on-skin, a wearable device for continuous monitoring of health-critical biomarkers. Let’s get right to it.
Visit TPM 25 for highlights and links from this episode.
2021-09-0531 minTalking Precision MedicineFostering Patient Journeys Around the World | Talking Precision Medicine #24Our guest is Dr. Angeli Moeller, Head of Pharma International Informatics at Roche. Angeli and our host, Rafael, discuss data science in the big pharma leagues; geek out on data standards; and dive deep on patient data rights and barriers to care.
Visit TPM E24 for highlights and links from this episode.
2021-07-2840 minTalking Precision MedicineFrom Cancer to Covid, Drug Intelligent Science at Breakneck Pace | Talking Precision Medicine #23Our guest for this episode of Talking Precision Medicine is Liang Schweizer from HiFiBiO Therapeutics - one of the most exciting young biotechs out there. They have built a discovery engine encompassing single cell, immune profiling and machine learning.
Visit TPM E23 for highlights and links from this episode.
2021-02-2647 minTalking Precision MedicineEthics and Policies of Precision Medicine on the Global Stage | Talking Precision Medicine #22Our guests for this episode of Talking Precision Medicine are Elissa Prichep and Cameron Fox of the World Economic Forum. Elissa and Cameron take us through the W.E.F’s precision medicine initiative, and explain how anticipating ethical tensions is key to envisioning policies for precision medicine across the globe.
Visit TPM E22 for highlights and links from this episode.
2020-11-1949 minTalking Precision MedicineRebooting generics to fight cancer | Talking Precision Medicine #21Reboot Rx is a different kind of biotech startup. Reboot’s mission is to find generic non-cancer drugs that can benefit cancer patients quickly and affordably. And as a not-for-profit, Reboot can stay focused on its mission. Given the number of paradigms Reboot hopes to shift at once, we decided to talk with all three co-founders: CEO Laura Kleiman, COO & CTO Pradeep Mangalath and CSO Catherine Del Vecchio Fitz. Each one provides perspective on their part of the puzzle.
Visit TPM E21 for highlights and links from this episode.
2020-08-3151 minTalking Precision MedicineStopping sepsis in its tracks… oh, and COVID19 too! | Talking Precision Medicine #20Today Rafael is joined by Dr. Sarma Velamuri, founder and CEO of Luminare. Luminare is a Houston-based digital health company dedicated to ending sepsis—the number 1 cause of death in US hospitals. In the conversation that follows, Dr. Velamuri explains how Luminare saves lives by streamlining hospital workflows, and by changing the behaviors of nurses and doctors. They’ve also made a giant leap into covid tracking, emerging as national leaders on this front.
Visit TPM E20 for highlights and links from this episode.
2020-06-1146 minTalking Precision MedicineMeet the viruses that are saving lives with Rob McBride | Talking Precision Medicine #19Today’s news is dominated by the corona virus and COVID-19 pandemic. Rightfully so. But today we’re bringing you a story of another class of viruses, called Phage. Phage are viruses that find and kill bacteria, and Felix is a Bay Area biotech harnessing the power of phage to fight the scourge of antibiotic resistant infections. So join our conversation with founder and CEO, Dr. Rob McBride, from wherever you have socially distanced yourself or locked down on quarantine, and learn about the viruses that are actually saving lives.
Visit TPM E19 for highlights and links from this ep
2020-03-1736 minTalking Precision MedicineDNA solves the oldest cold case with David Mittelman | Talking Precision Medicine #18Today’s episode is a bit different — different in that we are rejoined by a previous guest — David Mittelman. David is CEO of Othram, the first genomics-based forensics company. The audience response to our first conversation was so overwhelming we wanted to have David back on. And the timing couldn’t be better. Since our last chat, David and Othram have been all over the news, and have launched a new database product.
Visit TPM E18 for highlights and links from this episode.
2020-03-0433 minTalking Precision MedicineLaunching the Hubble Telescope to Cure Cancer with Charlie Silver and Nigel Beard | Talking Precision Medicine #17Today our guests are Charlie Silver and Nigel Beard. Charlie is CEO, and Nigel CTO, of Mission Bio. Mission Bio is a single-cell analysis platform company empowering researchers to cure cancer. They are the first company to deliver simultaneous measurement of the genotype and phenotype at single-cell resolution. In this episode, we talk about the audacious mission at Mission Bio, and how their groundbreaking platform enables a whole new set of questions to be answered in cancer research. We also go deep on potential clinical applications and the future of single-cell multi-omic datasets.
Visit TPM E17 for highligh...
2020-01-0938 minTalking Precision MedicineBuilding the Team to Decode Biology with Tina Larson | Talking Precision Medicine #16Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine.
This show is brought to you by Genialis, and Rafael, our CEO, is your host. Genialis is focused on data integration and predictive modeling of disease biology to help accelerate the discovery and de-risk the development of novel t...
2019-11-0537 minTalking Precision MedicineThe Genomics of Justice with David Mittelman | Talking Precision Medicine #15Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine.
This show is brought to you by Genialis, and Rafael, our CEO, is your host. Genialis is focused on data integration and predictive modeling of disease biology to help accelerate the discovery and de-risk the development of novel t...
2019-10-1039 minTalking Precision MedicineGarbage in, garbage out? Solve data preprocessing with Gabe Musso | Talking Precision Medicine #14Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine.
This show is brought to you by Genialis, and Rafael, our CEO, is your host. Genialis is focused on data integration and predictive modeling of disease biology to help accelerate the discovery and de-risk the development of novel th...
2019-09-1736 minTalking Precision MedicineTwenty-two suicides, every damn day with Yusuf Henriques | Talking Precision Medicine #13Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.
Genialis is focused on data integration and predictive modeling of disease biology to help accelerate the discovery and de-risk the development of novel...
2019-07-2334 minTalking Precision MedicineOrganizing the world’s variant data for genomic medicine with Mark Kiel | Talking Precision Medicine #12In Talking Precision Medicine podcast we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.
Genialis is focused on data integration and predictive modeling of disease biology to help accelerate the discovery and de-risk the development of novel therapeutics.
...
2019-06-1439 minTalking Precision MedicineThe evolving business landscape of health-tech with Luba Greenwood | Talking Precision Medicine #11In Talking Precision Medicine podcast we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.
Genialis is focused on data integration and predictive modeling of disease biology to help accelerate the discovery and de-risk the development of novel therapeutics.
...
2019-05-2828 minTalking Precision MedicineThe hottest time in gene therapy, ever! with Nicole Paulk | Talking Precision Medicine #10In Talking Precision Medicine podcast we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.
Genialis is focused on data integration and predictive modeling of disease biology to help accelerate the discovery and de-risk the development of novel therapeutics.
...
2019-04-3031 minTalking Precision MedicineBuilding trust in rare disease with Julie Walters | Talking Precision Medicine #09In Talking Precision Medicine podcast we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.
Genialis is focused on data integration and predictive modeling of disease biology to help accelerate the discovery and de-risk the development of novel therapeutics.
To...
2019-04-0228 minTalking Precision MedicineStanding up the Alliance for AI in Healthcare with Annastasiah Mhaka | Talking Precision Medicine #08In Talking Precision Medicine podcast we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.
Genialis is focused on data integration and predictive modeling of disease biology… to help accelerate the discovery and de-risk the development of novel therapeutics.
Today’s podc...
2019-03-0536 minTalking Precision MedicineModeling systems from organoids to EHRs with Olivier Elemento | Talking Precision Medicine #07In Talking Precision Medicine podcast we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.
Genialis is focused on data integration and predictive modeling of disease biology… to help accelerate the discovery and de-risk the development of novel therapeutics.
...
2019-02-1938 minTalking Precision MedicineWhere were you when the FDA approved CAR-T? with Patrick Hanley | Talking Precision Medicine #06In Talking Precision Medicine podcast we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.
Genialis is focused on data integration and predictive modeling of disease biology… to help accelerate the discovery and de-risk the development of novel therapeutics.
...
2019-02-0531 minTalking Precision MedicineLong on evidence, strong on science with Matthew Michelson | Talking Precision Medicine #05In Talking Precision Medicine podcast we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.
Genialis is focused on data integration and predictive modeling of disease biology… to help accelerate the discovery and de-risk the development of novel therapeutics.
...
2019-01-2239 minTalking Precision MedicineThe organic intelligence of families in need with Ethan Perlstein | Talking Precision Medicine #04In Talking Precision Medicine podcast we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.
Genialis is focused on data integration and predictive modeling of disease biology… to help accelerate the discovery and de-risk the development of novel therapeutics.
2019-01-0830 minTalking Precision MedicineThe data-driven storyteller with Elia Stupka | Talking Precision Medicine #03In Talking Precision Medicine podcast we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host. Genialis is focused on data integration and predictive modeling of disease biology… to help accelerate the discovery and de-risk the development of novel therapeutics. Today we speak with Elia Stupka. El...
2018-12-1932 minTalking Precision MedicineAI could be made illegal tomorrow with Jonny Wray | Talking Precision Medicine #02In Talking Precision Medicine podcast we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host. Genialis is focused on data integration and predictive modeling in precision medicine. We help accelerate the discovery and de-risk the development of novel therapeutics. From heterogeneous data and diverse information...
2018-12-1230 minTalking Precision MedicineAI, it’s all about the drugs with Asim Siddiqui | Talking Precision Medicine #01In Talking Precision Medicine podcast we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.
Genialis is focused on data integration and predictive modeling in precision medicine. We help accelerate the discovery and de-risk the development of novel therapeutics. From heterogeneous data and diverse information stores...
2018-11-2832 min